188 related articles for article (PubMed ID: 16204244)
1. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
[TBL] [Abstract][Full Text] [Related]
2. Hemextin AB complex--a snake venom anticoagulant protein complex that inhibits factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
Pathophysiol Haemost Thromb; 2005; 34(4-5):184-7. PubMed ID: 16707924
[TBL] [Abstract][Full Text] [Related]
3. Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.
Girish VM; Kini RM
Sci Rep; 2016 Aug; 6():32036. PubMed ID: 27558950
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus.
Banerjee Y; Lakshminarayanan R; Vivekanandan S; Anand GS; Valiyaveettil S; Kini RM
Biophys J; 2007 Dec; 93(11):3963-76. PubMed ID: 17704148
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray diffraction analysis of hemextin A: a unique anticoagulant protein from Hemachatus haemachatus venom.
Banerjee Y; Kumar S; Jobichen C; Kini RM
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug; 63(Pt 8):701-3. PubMed ID: 17671372
[TBL] [Abstract][Full Text] [Related]
6. Ringhalexin from Hemachatus haemachatus: A novel inhibitor of extrinsic tenase complex.
Barnwal B; Jobichen C; Girish VM; Foo CS; Sivaraman J; Kini RM
Sci Rep; 2016 May; 6():25935. PubMed ID: 27173146
[TBL] [Abstract][Full Text] [Related]
7. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
[TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa.
Dennis MS; Roberge M; Quan C; Lazarus RA
Biochemistry; 2001 Aug; 40(32):9513-21. PubMed ID: 11583150
[TBL] [Abstract][Full Text] [Related]
10. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
11. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
[TBL] [Abstract][Full Text] [Related]
12. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
13. Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phage.
Maun HR; Eigenbrot C; Lazarus RA
J Biol Chem; 2003 Jun; 278(24):21823-30. PubMed ID: 12657647
[TBL] [Abstract][Full Text] [Related]
14. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Frédérick R; Pochet L; Charlier C; Masereel B
Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
[TBL] [Abstract][Full Text] [Related]
15. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
[TBL] [Abstract][Full Text] [Related]
16. Proteomic and toxinological characterization of the venom of the South African Ringhals cobra Hemachatus haemachatus.
Sánchez A; Herrera M; Villalta M; Solano D; Segura Á; Lomonte B; Gutiérrez JM; León G; Vargas M
J Proteomics; 2018 Jun; 181():104-117. PubMed ID: 29656017
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
18. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
[TBL] [Abstract][Full Text] [Related]
19. Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.
Shah K; Bayoumi R; Banerjee Y
Hematology; 2013 Jan; 18(1):1-7. PubMed ID: 22980919
[TBL] [Abstract][Full Text] [Related]
20. In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa.
Al-Amri MS; Alrasadi K; Bayoumi R; Banerjee Y
Sultan Qaboos Univ Med J; 2011 Feb; 11(1):83-94. PubMed ID: 21509213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
